Security key
05280R100
Autolus Therapeutics plc - Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share (AUTL)
CUSIP: 05280R100
Q1 2021 13F Holders as of 31 Mar 2021
- Type / Class
- Equity / Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share
- Shares outstanding
- 266,837,198
- Total 13F shares
- 22,400,702
- Share change
- +9,806,691
- Total reported value
- $128,321,739
- Price per share
- $5.73
- Number of holders
- 58
- Value change
- +$53,655,759
- Number of buys
- 38
- Number of sells
- 14
Report period
Q1 2021
Institutions
58
Top holders
10
AUTL full security history
Newer quarter: Q2 2021
Previous quarter: Q4 2020
Autolus Therapeutics plc SEC filings
Autolus Therapeutics plc company facts
Broader feeds
Reporting periods
Holder history for CUSIP 05280R100
Recent filing periods:
Top shareholders of AUTL - Autolus Therapeutics plc - Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Capital World Investors |
13F
|
Company |
1.1%
|
2,955,806
|
$26,425,000 | — | 31 Dec 2020 | |
| Tetragon Partners GP Ltd |
13F
|
Company |
0.81%
|
2,150,000
|
$19,221,000 | — | 31 Dec 2020 | |
| SCHRODER INVESTMENT MANAGEMENT GROUP |
13F
|
Company |
0.63%
|
1,672,732
|
$14,954,000 | — | 31 Dec 2020 | |
| Capital International Investors |
13F
|
Company |
0.46%
|
1,222,688
|
$10,931,000 | — | 31 Dec 2020 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.29%
|
782,183
|
$6,993,000 | — | 31 Dec 2020 | |
| Alphabet Inc. |
13F
|
Company |
0.26%
|
698,262
|
$6,242,000 | — | 31 Dec 2020 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.21%
|
570,455
|
$5,100,000 | — | 31 Dec 2020 | |
| Granahan Investment Management, LLC |
13F
|
Company |
0.17%
|
465,795
|
$4,164,000 | — | 31 Dec 2020 | |
| Cormorant Asset Management, LP |
13F
|
Company |
0.16%
|
422,167
|
$3,774,000 | — | 31 Dec 2020 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.11%
|
300,260
|
$2,684,000 | — | 31 Dec 2020 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.1%
|
254,260
|
$2,273,000 | — | 31 Dec 2020 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
0.06%
|
165,809
|
$1,482,000 | — | 31 Dec 2020 | |
| Eversept Partners, LP |
13F
|
Company |
0.06%
|
154,981
|
$1,385,530 | — | 31 Dec 2020 | |
| MORGAN STANLEY |
13F
|
Company |
0.05%
|
129,208
|
$1,155,000 | — | 31 Dec 2020 | |
| FMR LLC |
13F
|
Company |
0.04%
|
112,767
|
$1,008,000 | — | 31 Dec 2020 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.03%
|
80,956
|
$724,000 | — | 31 Dec 2020 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.03%
|
79,120
|
$707,000 | — | 31 Dec 2020 | |
| Pendal Group Ltd |
13F
|
Company |
0.02%
|
50,354
|
$450,000 | — | 31 Dec 2020 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.02%
|
44,417
|
$397,000 | — | 31 Dec 2020 | |
| MPM BioImpact LLC |
13F
|
Company |
0.01%
|
39,740
|
$355,000 | — | 31 Dec 2020 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.01%
|
34,323
|
$307,000 | — | 31 Dec 2020 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.01%
|
30,873
|
$276,000 | — | 31 Dec 2020 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.01%
|
26,739
|
$239,000 | — | 31 Dec 2020 | |
| STATE STREET CORP |
13F
|
Company |
0.01%
|
22,534
|
$201,000 | — | 31 Dec 2020 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.01%
|
19,008
|
$170,000 | — | 31 Dec 2020 | |
| Weiss Multi-Strategy Advisers LLC |
13F
|
Company |
0.01%
|
18,526
|
$166,000 | — | 31 Dec 2020 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.01%
|
15,783
|
$141,000 | — | 31 Dec 2020 | |
| Burrage Capital Management LLC |
13F
|
Company |
0.01%
|
15,006
|
$134,000 | — | 31 Dec 2020 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.01%
|
14,385
|
$129,000 | — | 31 Dec 2020 | |
| Aperio Group, LLC |
13F
|
Company |
0%
|
12,419
|
$111,000 | — | 31 Dec 2020 | |
| Legal & General Group Plc |
13F
|
Company |
0%
|
10,891
|
$97,000 | — | 31 Dec 2020 | |
| UBS Group AG |
13F
|
Company |
0%
|
5,544
|
$50,000 | — | 31 Dec 2020 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
5,100
|
$46,000 | — | 31 Dec 2020 | |
| American Portfolios Advisors |
13F
|
Company |
0%
|
4,750
|
$42,465 | — | 31 Dec 2020 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
1,612
|
$14,000 | — | 31 Dec 2020 | |
| RBC Europe Ltd |
13F
|
Company |
0%
|
1,400
|
$12,516 | — | 31 Dec 2020 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
1,017
|
$9,000 | — | 31 Dec 2020 | |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. |
13F
|
Company |
0%
|
1,000
|
$9,000 | — | 31 Dec 2020 | |
| Penserra Capital Management LLC |
13F
|
Company |
0%
|
795
|
$7,000 | — | 31 Dec 2020 | |
| Lindbrook Capital, LLC |
13F
|
Company |
0%
|
607
|
$5,000 | — | 31 Dec 2020 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
564
|
$5,000 | — | 31 Dec 2020 | |
| US BANCORP \DE\ |
13F
|
Company |
0%
|
539
|
$5,000 | — | 31 Dec 2020 | |
| Parallel Advisors, LLC |
13F
|
Company |
0%
|
229
|
$2,000 | — | 31 Dec 2020 | |
| Derivatives Exane |
13F
|
Individual |
0%
|
180
|
$1,609 | — | 31 Dec 2020 | |
| BARCLAYS PLC |
13F
|
Company |
0%
|
148
|
$1,000 | — | 31 Dec 2020 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
114
|
$1,000 | — | 31 Dec 2020 | |
| Daiwa Securities Group Inc. |
13F
|
Company |
0%
|
74
|
$1,000 | — | 31 Dec 2020 |
Institutional Holders of Autolus Therapeutics plc - Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share (AUTL) as of Q1 2021
As of 31 Mar 2021,
Autolus Therapeutics plc - Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share (AUTL) was held by
58 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
22,400,702 shares.
The largest 10 holders included
Capital World Investors, Polygon Management Ltd., Capital International Investors, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), Opaleye Management Inc., FMR LLC, SCHRODER INVESTMENT MANAGEMENT GROUP, Ikarian Capital, LLC, Alphabet Inc., and JPMORGAN CHASE & CO.
This page lists
58
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2021 vs Q4 2020 Across Filers
Q4 2020 holders
46
Q1 2021 holders
58
Holder diff
12
| Investor | Q4 2020 Shares | Q1 2021 Shares | Share Diff | Share Chg % | Q4 2020 Value $ | Q1 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.